Anthropic CEO Dario Amodei says artificial intelligence could trigger a biotech renaissance, accelerating breakthroughs in peptide drugs, CAR-T therapies, and programmable biology through AI-assisted ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
PARIS--(BUSINESS WIRE)--Regulatory News: Acticor Biotech, (ISIN: FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of ...
Biotechnology has emerged as a fundamental solution for addressing the multidimensional challenges of food security in Nigeria. Experts told the News Agency of Nigeria (NAN) on Wednesday in Abuja that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results